How to Evaluate a Cardiac Remote Monitoring Platform

A five-question standard for reading the vendor rankings, scorecards, and comparisons you find online.

If your team has searched for a cardiac remote monitoring vendor recently, you have probably found ranking articles, scorecards, and “best platform” lists. Many are written by vendors, published on the vendor’s own site, and rank that vendor first. 

They usually arrive as a cluster rather than a single article, and they share a structure: 

• Built around a competitor’s name. Pages are written to surface when you search a specific vendor, product, or even its login page.

• Styled as neutral guides. Buyer’s guides, comparisons, and “alternatives” lists, with the publisher recommended in each one.

• Self-published rankings. The publisher writes the ranking, hosts it, and places itself first, with no analyst firm, rubric, or methodology named.

• Contradictions across one site. A single publisher can produce several different orderings of the same market, and repeat the same headline percentages with no study or baseline behind them.

• Pages that mimic support documentation. A search for help with software you already license can land on a competitor’s demo request. 

Your decision deserves better than that. Choosing a platform for cardiac implantable electronic devices (CIEDs) shapes clinical workflow, alert burden, EHR integration, reimbursement capture, staff capacity, and patient follow-up for years. 

Here is a standard you can apply to any vendor, including us. 

Five questions to ask every vendor:

What PaceMate puts on the record

Every figure below is on the record and available, with full methodology included, for review with your team.

• Experience. More than ten years managing remote device data for cardiac programs.
• Scale. More than 2.3 million patients managed.
• Published evidence. 33 peer-reviewed publications.
• Device breadth. 14 integrated device manufacturers across implantables, wearables, ambulatory monitors, and remote patient monitoring.
• Security. ISO/IEC 27001:2022 certification, the international standard for information security management.

What we do not claim

We do not publish a ranking of our competitors. We do not assign ourselves a score. We do not put a percentage on your program’s revenue before we have seen your baseline, payer mix, staffing model, and billing workflow. Any vendor that does, including one quoting a number about us, is modeling rather than measuring.

Where this applies

Use this for any platform evaluation, whether you are reviewing one vendor, comparing several, or planning a migration from a legacy on-premise system.

In short

• A percentage without a baseline, a patient count, and a measurement period is not a finding.
• Ask for the evidence behind every number, from every vendor, including this one.
• Search results are not the same as clinical validation

Next step

Bring these five questions to every vendor on your list. Ask us first if you like. To review the evidence behind any figure here with your device team, contact your PaceMate representative or request a platform review at pacemate.com.